Deceptive health claims and improper disclosures are areas in which the FTC will focus its monitoring and enforcement efforts in the coming year, according to the commission’s top official.
“[FTC] will work to ensure that health claims are backed by real and rigorous evidence, especially when those claims relate to serious health conditions,” Chairwoman Edith Ramirez said during her keynote presentation Sept. 29
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?